Jill Fichtel, MD
Dr. Jill Fichtel, Nashville native, Board certified Dermatologist, CEO and Founder of SCTCN has spent her 20+ year career staying on the cutting edge of beauty and antiaging, focusing on using natural, regenerative products and energy based devices to restore youth and function. Her motivation has always been her own journey of seeking and testing these technologies and then sharing the successes with her patients. Maximum safety and effectiveness, with minimal discomfort and risk have always been her standards at the forefront of her mind when evaluating new technologies to offer.
Dr. Jill’s more recent motivation behind the creation of Stem Cell Therapy Center of Nashville has been a mother’s love. Her daughter was diagnosed with Type 1 Diabetes at the age of 9, but Dr. Jill has stayed hopeful for a cure as reports of cures and stabilization of diabetes using stem cells have surfaced from around the world. For this reason, stem cells have been on her radar for many years, and the regenerative effects she has witnessed using autologous PRP and stem cells from fat in her practice at Transformative Dermatology, have further enhanced her passion. After many years of research, safety data, and her own personal improvement in her arthritis, Dr. Jill is excited to offer these technologies to her patients. “These natural cells that can rebuild and regenerate is giving hope to people who want a natural cure or to people who have reached the end of their rope with traditional Western medicine”- Dr. Jill. Even though stem cells are not FDA approved for anything, Dr. Jill is of the mindset that “although they aren’t “approved” for anything specific, that doesn’t mean they can’t help with everything… that’s the nature of stem cells”. Even a study out of Harvard is showing promising preliminary results in Type 1 diabetes using stem cell pancreatic transplants, which further validates her belief in a potential cure for her daughter, and many other autoimmune problems, using regenerative therapies.
“My heart is full with the potential and hope that stem cell therapies hold the key for true healing, not only in the future, but NOW, and I am excited to offer these technologies to my patients on our mutual journey of feeling better, looking better, living better and loving better” – Dr. Jill.
Dr. Jill loves living her Faith, spending time with her Family and Friends and feels blessed to be able to care for and offer healing opportunities for her patients. She loves her amazing staff who are also her dear friends, Michelle, Lori, Jess and Elisha and of course Spice, her tea cup poodle who gives unconditional love to all. She loves to travel, especially to the beach, garden, swim, play piano and be in nature.
Certification & Licensure
- Tennessee Board of Medicine
- American Board of Dermatology
Degrees
- M.D. University of Tennessee College of Medicine, Memphis, TN
- B.Sc. (Biology) University of Tennessee, Martin, TN
- University of Alabama, Tuscaloosa, AL
Post-Graduate Training
- Department of Dermatology, Medical College of Georgia, Augusta, GA
- University of Tennessee, Baptist Hospital, Nashville, TN
Research Activity & Clinical Trials
- An open-label study to evaluate the long-term safety of topical administration of FMX103 for 40 weeks in the treatment of moderate to severe facial papulopustular rosacea (Study FX2016-13)
- A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of dupilumab monotherapy in patients ≥12 to <18 years of age, with moderate-to-severe atopic dermatitis
- A randomized, multicenter, double-blind, vehicle-controlled study to evaluate the safety and efficacy of FMX103 1.5% topical minocycline foam compared to vehicle in the treatment of facial papulopustular rosacea
Publications
- Zirwas MJ, Fichtel J. Chlorine Dioxide Complex Cleanser: A New Agent With Rapid Efficacy for Keratosis Pilaris. J Drugs Dermatol. 2018 May 1;17(5):554-556. PubMed PMID: 29742188.
- Fichtel JC, Richards JA, Davis LS. Trichorrhexis nodosa secondary to argininosuccinicaciduria. Pediatr Dermatol. 2007 Jan-Feb;24(1):25-7. PubMed PMID: 17300644.
- Fichtel JC, Duckworth AK, Soares T, Lesher JL Jr. Subcutaneous sarcoidosis presenting after treatment of Cushing’s disease. J Am Acad Dermatol. 2006 Feb;54(2):360-1. PubMed PMID: 16443078.
- Fichtel JC, Wiggins AK, Lesher JL Jr. Plaque-forming demodicidosis. J Am Acad Dermatol. 2005 Feb;52(2 Suppl 1):59-61. PubMed PMID: 15692519.
Selected National and Regional CME Presentations
- Fichtel J. Advanced Uses of Fillers, Toxins and BodySculpting Devices. American Osteopathic College of Dermatology Annual Meeting. Nashville, TN. September 2019.
- Fichtel J. Advanced Uses of Platelet Rich Plasma. Cosmetic Surgery Forum. Las Vegas, NV. November 2019.
Stem Cell Therapy Center of Nashville
1909 Mallory Lane
Suite 302D, Franklin, TN 37067
(615) 905-4994
